QA: Rezolute Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2020_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.16206963374459013, 'aggregate_val': 25944000, 'exp_sum': 30962000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 6820000, 'ResearchAndDevelopmentExpense': 19079000, 'remainder_Expenses': 5063000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001509261')"}

Graph

Absolute values for 0001509261, Rezolute Inc.

  xvar xval
0 AssetsCurrent 12,144,000
1 IntangibleAssetsNetIncludingGoodwill 29,000
2 PropertyPlantAndEquipmentNet 44,000
3 remainder_Assets 35,000
4 LiabilitiesCurrent 8,379,000
5 LiabilitiesNoncurrent 121,000
6 remainder_Liabilities 2,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,820,000
9 ResearchAndDevelopmentExpense 19,079,000
10 remainder_Expenses 45,000
11 remainder_Revenues 0
12 remainder_NetIncome -4,502,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 12,252,000
1 Liabilities 10,500,000
2 Expenses 25,944,000
3 Revenues 0
4 StockholdersEquity 1,752,000
5 NetIncome -30,446,000
6 ComprehensiveNetIncome -30,446,000
7 BaseVar 26,599,000
8 EconomicCapitalRatio -2.41

Edgar->Model Mapping

Feature Distribution

Change over Time